34201-01-9

Basic information

• Product Name: 3,4-DIHYDRO-2H-PYRAN-2-CARBOXYLIC ACID
• Synonyms: 2H-PYRAN-2-CARBOXYLIC ACID, 3,4-DIHYDRO-;3,4-DIHYDRO-2H-PYRAN-2-CARBOXYLIC ACID
• CAS NO: 34201-01-9
• Molecular Formula: C₆H₈O₃
• Molecular Weight: 128.13
• EINECS: 251-875-2
• Mol File: 34201-01-9.mol

Chemical Properties

• Boiling Point: 278.3 °C at 760 mmHg
• Flash Point: 122.5 °C
• Appearance: /
• Density: 1.243 g/cm³
• CAS DataBase Reference: 3,4-DIHYDRO-2H-PYRAN-2-CARBOXYLIC ACID(CAS DataBase Reference)
• NIST Chemistry Reference: 3,4-DIHYDRO-2H-PYRAN-2-CARBOXYLIC ACID(34201-01-9)
• EPA Substance Registry System: 3,4-DIHYDRO-2H-PYRAN-2-CARBOXYLIC ACID(34201-01-9)

Safety Data

• Statements: 36/37/38
• Safety Statements: 26-36/37/39
• Hazardous Substances Data: 34201-01-9(Hazardous Substances Data)

Usage

Uses

Used in Pharmaceutical Applications:
3,4-Dihydro-2H-pyran-2-carboxylic acid is used as a pharmaceutical agent for its potential biological activity. It is being investigated for its possible use in developing new drugs and therapies due to its unique chemical structure and properties.
Used in Organic Synthesis:
In the field of organic chemistry, 3,4-Dihydro-2H-pyran-2-carboxylic acid is used as a precursor in the synthesis of other organic compounds. Its versatile structure allows it to be a valuable building block for creating a variety of molecules with different applications.
Used in Polymer Chemistry and Material Science:
3,4-Dihydro-2H-pyran-2-carboxylic acid is also being studied for its potential role in polymer chemistry and material science. Its cyclic structure and functional groups may contribute to the development of new polymers and materials with unique properties and applications.

InChI:InChI=1/C6H8O3/c7-6(8)5-3-1-2-4-9-5/h2,4-5H,1,3H2,(H,7,8)

Upstream product

• 100-73-2 acrolein dimer 

Downstream Products

• 83568-11-0 racem. ethyl 3,4-dihydro-2H-pyran-2-carboxylate 

Relevant articles and documents

CCR2 MODULATORS

Compounds are provided that are modulators of the CCR2 receptor. The compounds have the general formula (I) and are useful in pharmaceutical compositions, methods for the treatment of diseases and disorders involving the pathologic activtation of CCR2 receptors.

Antiparasitic agents

The invention provides novel compounds having the formula: STR1 wherein R when taken individually is H; R1 when taken individually is H or OH; R and R1 when taken together represent a double bond; R2 is an alpha-branched C3 -C8 alkyl, alkenyl, alkynyl, alkoxyalkyl or alkylthioalkyl group; a C3 -C8 cycloalkyl, C5 -C8 cycloalkenyl or C5 -C8 cycloalkylalkyl group, any of which may be substituted by methylene or one or more C1 -C4 alkyl groups or halo atoms; or a 3 to 6 membered oxygen or sulphur containing heterocyclic ring which may be substituted by one or more C1 -C4 alkyl groups or halo atoms; R3 is hydrogen or methyl; R4 is H or 4'-(alpha-L-oleandrosyl)-alpha-L-oleandrosyloxy with the proviso that when R2 is alkyl it is not isopropyl or sec-butyl; when R4 is H, each of R and R1 is H, and R2 is not methyl or ethyl; and when R4 is H, R is H, R1 is OH, and R2 is not 2-buten-2-yl, 2-penten-2-yl or 4-methyl-2-penten-2-yl. The compounds are broad spectrum antiparasitic agents having utility as anthelmintics, ectoparasiticides, insecticides and acaricides. The invention also provides a process for producing the novel avermectin and milbemycin derivatives by adding a carboxylic acid or derivative thereof to a fermentation of an avermectin or milbemycin producing organism.